The One Big Beautiful Bill Becomes Law: Key Real Estate Tax Changes

Signed into law on July 4, 2025, by President Trump, the One Big Beautiful Bill Act has ushered in significant changes to the landscape of real estate taxation. This new legislation not only extends but also modifies key provisions from the Tax Cuts and Jobs Act of 2017, providing a fresh wave of business incentives and reforms that are particularly beneficial to the real estate industry.

The Act’s implications are far-reaching. It offers a myriad of opportunities for taxpayers to reduce their tax burdens, with notable expansions in benefits for Opportunity Zone investors. This move is expected to increase the availability of low-income housing and new markets tax credits, fostering a more inclusive economic environment.

Congress passes amendments

Interestingly, the Act omits some of the more controversial proposals from previous versions, such as the so-called “Revenge Tax.” Instead, it introduces new incentives for qualified production activities, which are poised to encourage onshoring of manufacturing.

Key Provisions

One of the standout features of the Act is the permanent extension of the 20% deduction under Section 199A for certain individuals, trusts, and estates. This extension is a boon for those involved with partnerships, S corporations, and sole proprietorships, as well as those receiving qualified REIT dividends.

Moreover, the Act reinstates the 100% bonus depreciation under Section 168(k) for qualified property, a move that is expected to stimulate economic activity by encouraging investment in tangible personal property.

Looking Ahead

As the real estate sector begins to navigate these changes, all eyes will be on the Internal Revenue Service (IRS) and the Treasury for further guidance. The continuous monitoring and updates from these bodies will be crucial in ensuring that businesses and investors can effectively leverage the new opportunities presented by the Act.

For more detailed insights, readers can explore the impact on energy-related tax credits and other related topics on the Jones Day website.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Donald Trump’s Historic Re-Election as U.S. President

In a stunning political comeback, Donald Trump has been re-elected as President of the United States, marking a significant moment in American history. This victory followed a fiercely contested race against Kamala Harris.

By |November 6, 2024|Categories: Article, Politics, U.S. Election|Tags: |0 Comments

AI Transformation in Healthcare: A Market on the Brink of Explosive Growth

The AI in Healthcare market, valued at USD 22.5 billion in 2023, is projected to skyrocket to USD 370.14 billion by 2032. This growth is fueled by a remarkable compound annual growth rate (CAGR) of 36.5%.

Propy Revolutionizes Home Inspections with Inspectify Partnership

Propy, a San Francisco-based real estate technology platform, has announced its strategic partnership with Inspectify, a leading property inspection platform. This collaboration... enables users to handle property inspections without leaving the Propy app, marking a new era of efficiency in real estate transactions.

AI’s Transformative Impact on the Insurance Sector Unveiled at Hong Kong FinTech Week 2024

"AI has evolved from a competitive advantage to an essential survival tool." Its ability to streamline claims handling, enhance transparency, and combat fraud is revolutionizing insurance operations.

By |November 5, 2024|Categories: Article, Finance, Technology|Tags: , |0 Comments

The Dawn of Artificial Intelligence in Healthcare

The revolution of artificial intelligence (AI) in healthcare has just begun, with vast potential to transform patient care, research, and drug discovery.